-31.0%
MRNA vs ALK
-36.6%
+5.6%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | ALK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -5.9% | +3.7% | -0.4% |
| 7D | -12.7% | -12.3% | -0.4% | -9.3% |
| 30D | -20.7% | +0.6% | -21.2% | -20.9% |
| 3M | +46.3% | -16.1% | +62.3% | +53.8% |
| 6M | +305.2% | -15.4% | +320.6% | +318.3% |
| YTD | +561.2% | -32.9% | +594.2% | +621.1% |
| 1Y | +772.1% | -10.8% | +782.9% | +763.2% |
| 3Y | +147.0% | -9.6% | +156.6% | +123.0% |
| All | -31.0% | -36.6% | +5.6% | -29.7% |
Cumulative growth
Daily Returns
Daily percentage return beside ALK.
Daily Out/Under-Performance
Portfolio return minus ALK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded ALK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling